KTK Biotech is a Turkey-based startup founded in 2020, specializing in the production of biotech products used for research, development studies, and diagnostic purposes. The company operates within the Biotechnology and Life Sciences industries, aiming to make significant contributions to these fields.
With its slogan Episozyme, KTK Biotech positions itself as a player in the biotech market, with a focus on innovative solutions. While specific details about their last investment and the involved investors are currently unavailable, the company's potential within the biotech sector speaks to opportunities for future partnerships and investments.